SCHEMBL30867489

SCHEMBL30867489

Cc1nc(F)ccc1Oc1cc(C(F)(F)F)ccc1C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.54
▸ ALDH1A1 P00352 2/20 0.54
▸ HPGD P15428 2/20 0.54
▸ HSD17B10 Q99714 2/20 0.54
▸ USP2 O75604 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ SORT1 Q99523 8/20 0.46
▸ SCN8A Q9UQD0 3/20 0.45
▸ SCN10A Q9Y5Y9 3/20 0.45
▸ MRGPRX4 Q96LA9 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31426521 0.89 SCN8A (0.44) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL30867386 0.88 CFTR (0.50) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL4661838 0.80 SCN8A (0.62) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL31426525 0.80 NOTUM (0.40) ALDH1A1HPGDSORT1MRGPRX4
SCHEMBL24518269 0.80 SCN10A (0.61) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL29571346 0.80 SCN10A (0.61) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL31426654 0.74 SCN8A (0.51) SCN8ASCN10A
SCHEMBL31426573 0.73 L3MBTL1 (0.35) KDM4EALDH1A1SORT1SCN10A
SCHEMBL30867514 0.73 SCN10A (0.38) KDM4EALDH1A1SORT1SCN8ASCN10A
SCHEMBL422034 0.73 ALDH1A1 (0.71) KDM4EALDH1A1HPGDHSD17B10USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583867-A2 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE Latigo Biotherapeutics, Inc. (US) 2025-07-16 — — EP disclosed
CN-119894509-A Sodium channel blocking compounds, derivatives thereof, and methods of use thereof 拉堤果生物医疗股份有限公司 2025-04-25 — — CN disclosed
WO-2024054622-A2 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE LATIGO BIOTHERAPEUTICS, INC. (US) 2024-03-14 — — WO disclosed
Send feedback